Skip to main content
. Author manuscript; available in PMC: 2019 Jul 29.
Published in final edited form as: Arthritis Rheum. 2005 Sep;52(9):2768–2773. doi: 10.1002/art.21256

Table 2.

HLA compatibility of SLE son–mother pairs compared with healthy son–mother pairs*

Locus/compatibility Patients Controls OR (95% CI) P
DRB11
 Bidirectional 9 (30) 6 (8) 5.0 (1.6–15.7) 0.006
 Mother from son’s perspective 4 (13) 11 (14) 0.9 (0.3–3.1) 0.88
 Son from mother’s perspective 3 (10) 9 (12) 0.8 (0.2–3.3) 0.79
DRB12
 Bidirectional 5 (19) 5 (7) 3.2 (0.9–12.2) 0.08
 Mother from son’s perspective 4 (15) 7 (9) 1.7 (0.5–6.4) 0.42
 Son from mother’s perspective 2 (7) 4 (5) 1.4 (0.2–8.3) 0.68
DQA1
 Bidirectional 11 (38) 16 (21) 2.3 (0.9–5.8) 0.081
 Mother from son’s perspective 4 (14) 7 (9) 1.6 (0.4–5.9) 0.50
 Son from mother’s perspective 3 (10) 13 (17) 0.6 (0.1–2.1) 0.39
DQB1
 Bidirectional 7 (27) 12 (16) 2.0 (0.7–5.7) 0.21
 Mother from son’s perspective 3 (12) 5 (7) 1.9 (0.4–8.4) 0.42
 Son from mother’s perspective 2 (8) 10 (13) 0.6 (0.1–2.7) 0.46
*

Values are the number (%) of subjects. The analyses were not adjusted for age or ethnicity. For DRB11, n = 30 patients and 76 controls; for DRB12, n = 27 patients and 75 controls; for DQA1, n = 29 patients and 76 controls; for DQB1, n = 26 patients and 76 controls. See Table 1 for descriptions of compatibility. SLE = systemic lupus erythematosus; OR = odds ratio; 95% CI = 95% confidence interval.

Basic DRB1 groups DRB1*01 through DRB1*14 sharing sequence similarities but not necessarily identical throughout the entire DRβl chain.

Specific alleles within DRB1 groups.